Hantz Financial Services’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
TCM
HI
DGM
JT
ACM
CP
Hantz Financial Services's ABVX Position: Q2 2026 in Review
Hantz Financial Services reduced its Abivax (ABVX) stake by 56% in Q2 2026, selling an estimated $152K and leaving 1,058 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.
Hantz Financial Services first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $321K in Q4 2025. 275 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.
- Hantz Financial Services held 1,058 shares of Abivax worth $141K as of Q2 2026.
- Hantz Financial Services sold 1,340 Abivax shares in Q2 2026, an estimated $152K.
- Abivax made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1256 holding.
- Hantz Financial Services first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
- Hantz Financial Services's Abivax position peaked at $321K in Q4 2025.
- 275 funds tracked by Wall St. Rank held Abivax as of Q2 2026.
Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.